Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)
If American healthcare does not start cleaning house to enable digital innovation, it will pay the price, and inevitably, the patient will as always, be the real victim.